|
Volumn 20, Issue 2, 2002, Pages 157-165
|
Diabetes mellitus and the risk of prostate cancer
a b,c c b,c
c
NONE
(United States)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIANGINA PECTORIS AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
CHLORPROPAMIDE;
GLIPIZIDE;
INSULIN;
NITRATE;
SULFONYLUREA;
TOLAZAMIDE;
TOLBUTAMIDE;
ADULT;
AGED;
ARTICLE;
CANCER INCIDENCE;
CANCER RISK;
CANCER STAGING;
CASE CONTROL STUDY;
CONTROLLED STUDY;
DIABETES MELLITUS;
DISEASE ASSOCIATION;
HOSPITAL;
HUMAN;
HUMAN TISSUE;
ISCHEMIC HEART DISEASE;
LOGISTIC REGRESSION ANALYSIS;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL RECORD;
PRIORITY JOURNAL;
PROSTATE CANCER;
PROSTATE HYPERTROPHY;
RACE DIFFERENCE;
RISK ASSESSMENT;
UNITED STATES;
AGED;
CASE-CONTROL STUDIES;
CONTINENTAL POPULATION GROUPS;
CORONARY DISEASE;
DIABETES COMPLICATIONS;
DIABETES MELLITUS;
ETHNIC GROUPS;
HUMANS;
HYPOGLYCEMIC AGENTS;
MALE;
MYOCARDIAL ISCHEMIA;
NEOPLASM STAGING;
NEW YORK CITY;
ODDS RATIO;
PROSTATIC HYPERPLASIA;
PROSTATIC NEOPLASMS;
RISK FACTORS;
SMOKING;
|
EID: 0036197922
PISSN: 07357907
EISSN: None
Source Type: Journal
DOI: 10.1081/CNV-120001141 Document Type: Article |
Times cited : (52)
|
References (36)
|